CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.50
-0.02 (-0.21%)
Sep 11, 2025, 12:41 PM EDT - Market open

CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $87.90 million. The enterprise value is $56.02 million.

Market Cap87.90M
Enterprise Value 56.02M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date Nov 11, 2025
Ex-Dividend Date n/a

Share Statistics

CervoMed has 9.25 million shares outstanding. The number of shares has increased by 43.26% in one year.

Current Share Class 9.25M
Shares Outstanding 9.25M
Shares Change (YoY) +43.26%
Shares Change (QoQ) +2.85%
Owned by Insiders (%) 31.44%
Owned by Institutions (%) 14.25%
Float 5.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.73
Forward PS n/a
PB Ratio 2.63
P/TBV Ratio 2.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.20
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.20

Current Ratio 8.20
Quick Ratio 7.73
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -54.21% and return on invested capital (ROIC) is -36.80%.

Return on Equity (ROE) -54.21%
Return on Assets (ROA) -33.63%
Return on Invested Capital (ROIC) -36.80%
Return on Capital Employed (ROCE) -73.43%
Revenue Per Employee $518,465
Profits Per Employee -$1.51M
Employee Count15
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.96% in the last 52 weeks. The beta is -6.24, so CervoMed's price volatility has been lower than the market average.

Beta (5Y) -6.24
52-Week Price Change -37.96%
50-Day Moving Average 8.75
200-Day Moving Average 6.75
Relative Strength Index (RSI) 51.35
Average Volume (20 Days) 116,216

Short Selling Information

The latest short interest is 331,391, so 3.58% of the outstanding shares have been sold short.

Short Interest 331,391
Short Previous Month 728,696
Short % of Shares Out 3.58%
Short % of Float 6.05%
Short Ratio (days to cover) 1.58

Income Statement

In the last 12 months, CervoMed had revenue of $7.78 million and -$22.61 million in losses. Loss per share was -$2.58.

Revenue7.78M
Gross Profit -14.38M
Operating Income -24.56M
Pretax Income -5.04M
Net Income -22.61M
EBITDA n/a
EBIT -24.56M
Loss Per Share -$2.58
Full Income Statement

Balance Sheet

The company has $33.53 million in cash and n/a in debt, giving a net cash position of $33.53 million or $3.62 per share.

Cash & Cash Equivalents 33.53M
Total Debt n/a
Net Cash 33.53M
Net Cash Per Share $3.62
Equity (Book Value) 33.44M
Book Value Per Share 3.61
Working Capital 33.44M
Full Balance Sheet

Cash Flow

Operating Cash Flow -23.31M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is -184.92%, with operating and profit margins of -315.76% and -290.75%.

Gross Margin -184.92%
Operating Margin -315.76%
Pretax Margin -290.75%
Profit Margin -290.75%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.26%
Shareholder Yield -43.26%
Earnings Yield -25.25%
FCF Yield n/a

Analyst Forecast

The average price target for CervoMed is $19.17, which is 101.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target $19.17
Price Target Difference 101.79%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 53.21%
EPS Growth Forecast (5Y) -26.65%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CervoMed has an Altman Z-Score of 6.39.

Altman Z-Score 6.39
Piotroski F-Score n/a